{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:54:05Z","timestamp":1791975245383,"version":"4.4.0"},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/ftd.0b013e318167d563","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T19:42:50Z","timestamp":1236109370000},"page":"196-202","source":"Crossref","is-referenced-by-count":54,"title":["Current Developments in Drug Testing in Oral Fluid"],"prefix":"10.1097","volume":"30","author":[{"given":"Kristof","family":"Pil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Verstraete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.forsciint.2004.11.023","article-title":"Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges.","volume":"150","author":"Verstraete","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R2-10-20210129","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.forsciint.2005.02.028","article-title":"Oral fluid collection: the neglected variable in oral fluid testing.","volume":"150","author":"Crouch","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R3-10-20210129","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.forsciint.2004.11.022","article-title":"Review: pharmacokinetics of illicit drugs in oral fluid.","volume":"150","author":"Drummer","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R4-10-20210129","first-page":"147","article-title":"Drug testing in oral fluid.","volume":"27","author":"Drummer","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"R5-10-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1196\/annals.1384.037","article-title":"Interpretation of oral fluid tests for drugs of abuse.","volume":"1098","author":"Cone","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R6-10-20210129","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00216-007-1245-8","article-title":"Bioanalytical procedures for determination of drugs of abuse in oral fluid.","volume":"388","author":"Samyn","year":"2007","journal-title":"Anal Bioanal Chem"},{"key":"R7-10-20210129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/FTD.0b013e3180307e5e","article-title":"Disposition of gamma-hydroxybutyric acid in conventional and nonconventional biologic fluids after single drug administration: issues in methodology and drug monitoring.","volume":"29","author":"Abanades","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R8-10-20210129","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jat\/31.5.288","article-title":"Pharmacokinetic properties of delta(9)-tetrahydrocannabinol in serum and oral fluid.","volume":"31","author":"Kauert","year":"2007","journal-title":"J Anal Toxicol"},{"key":"R9-10-20210129","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/jat\/28.6.394","article-title":"Relationship of Delta(9)-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis.","volume":"28","author":"Huestis","year":"2004","journal-title":"J Anal Toxicol"},{"key":"R10-10-20210129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1384.038","article-title":"Methamphetamine disposition in oral fluid, plasma, and urine.","volume":"1098","author":"Huestis","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"R11-10-20210129","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1373\/clinchem.2006.081547","article-title":"Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases.","volume":"53","author":"Peters","year":"2007","journal-title":"Clin Chem"},{"key":"R12-10-20210129","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/jat\/27.8.552","article-title":"Concentrations and ratios of amphetamine, methamphetamine, MDA, MDMA, and MDEA enantiomers determined in plasma samples from clinical toxicology and driving under the influence of drugs cases by GC-NICI-MS.","volume":"27","author":"Peters","year":"2003","journal-title":"J Anal Toxicol"},{"key":"R13-10-20210129","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1373\/clinchem.2005.052746","article-title":"Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA.","volume":"51","author":"Peters","year":"2005","journal-title":"Clin Chem"},{"key":"R14-10-20210129","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.forsciint.2006.03.033","article-title":"Correlation of Delta 9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Drager DrugTest.","volume":"161","author":"Laloup","year":"2006","journal-title":"Forensic Sci Int"},{"key":"R15-10-20210129","first-page":"1","article-title":"Analysis of drugs of abuse in saliva.","volume":"11","author":"Samyn","year":"1999","journal-title":"Forensic Sci Rev"},{"key":"R16-10-20210129","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jat\/30.9.645","article-title":"Detection of THCA in oral fluid by GC-MS-MS.","volume":"30","author":"Day","year":"2006","journal-title":"J Anal Toxicol"},{"key":"R17-10-20210129","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/jat\/30.7.409","article-title":"Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens.","volume":"30","author":"Moore","year":"2006","journal-title":"J Anal Toxicol"},{"key":"R18-10-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jat\/31.3.157","article-title":"A validated method for the detection of Delta 9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta 9-tetrahydrocannabinol in oral fluid samples by liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry.","volume":"31","author":"Quintela","year":"2007","journal-title":"J Anal Toxicol"},{"key":"R19-10-20210129","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jat\/30.7.413","article-title":"Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays.","volume":"30","author":"Moore","year":"2006","journal-title":"J Anal Toxicol"},{"key":"R20-10-20210129","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/jat\/31.4.187","article-title":"Detection of conjugated 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid.","volume":"31","author":"Moore","year":"2007","journal-title":"J Anal Toxicol"},{"key":"R21-10-20210129","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jat\/29.7.607","article-title":"Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.","volume":"29","author":"Niedbala","year":"2005","journal-title":"J Anal Toxicol"},{"key":"R22-10-20210129","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.drugalcdep.2006.03.015","article-title":"Cognition and motor control as a function of Delta(9)-THC concentration in serum and oral fluid: limits of impairment.","volume":"85","author":"Ramaekers","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"R23-10-20210129","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.forsciint.2004.08.002","article-title":"Driving under the influence of drugs: evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.","volume":"152","author":"Toennes","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R24-10-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.forsciint.2006.09.001","article-title":"Roadside detection of impairment under the influence of ketamine: evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine.","volume":"170","author":"Cheng","year":"2007","journal-title":"Forensic Sci Int"},{"key":"R26-10-20210129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/jat\/31.1.44","article-title":"Evaluation of ten oral fluid point-of-collection drug-testing devices.","volume":"31","author":"Walsh","year":"2007","journal-title":"J Anal Toxicol"},{"key":"R27-10-20210129","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/jat\/29.4.244","article-title":"An evaluation of selected oral fluid point-of-collection drug-testing devices.","volume":"29","author":"Crouch","year":"2005","journal-title":"J Anal Toxicol"},{"key":"R28-10-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/jat\/27.7.429","article-title":"An evaluation of rapid point-of-collection oral fluid drug-testing devices.","volume":"27","author":"Walsh","year":"2003","journal-title":"J Anal Toxicol"},{"key":"R29-10-20210129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.forsciint.2006.01.020","article-title":"Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC\/MS.","volume":"161","author":"Cirimele","year":"2006","journal-title":"Forensic Sci Int"},{"key":"R30-10-20210129","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.forsciint.2007.05.022","article-title":"Roadside oral fluid testing: comparison of the results of Drugwipe 5 and Drugwipe Benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.","volume":"175","author":"Pehrsson","year":"2008","journal-title":"Forensic Sci Int"},{"key":"R31-10-20210129","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/jat\/29.7.724","article-title":"Detection of cannabis use in drivers with the Drugwipe device and by GC-MS after Intercept device collection.","volume":"29","author":"Kintz","year":"2005","journal-title":"J Anal Toxicol"},{"key":"R32-10-20210129","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jat\/31.2.98","article-title":"Evaluation of a rapid oral fluid point-of-care test for MDMA.","volume":"31","author":"Wilson","year":"2007","journal-title":"J Anal Toxicol"},{"key":"R33-10-20210129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/09595230701247764","article-title":"Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.","volume":"26","author":"Davey","year":"2007","journal-title":"Drug Alcohol Rev"},{"key":"R34-10-20210129","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.forsciint.2004.12.042","article-title":"Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid.","volume":"150","author":"Cooper","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R35-10-20210129","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/jat\/30.4.274","article-title":"Assay of Delta9-tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device.","volume":"30","author":"Kauert","year":"2006","journal-title":"J Anal Toxicol"},{"key":"R36-10-20210129","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.forsciint.2006.03.004","article-title":"The recovery of illicit drugs from oral fluid sampling devices.","volume":"165","author":"Dickson","year":"2007","journal-title":"Forensic Sci Int"},{"key":"R37-10-20210129","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.forsciint.2006.06.047","article-title":"Comment on S. Dickson, A. Park, S. Nolan et al. The recovery of illicit drugs from oral fluid sampling devices. Forensic Science International, published on line (2006).","volume":"169","author":"Soares","year":"2007","journal-title":"Forensic Sci Int"},{"key":"R38-10-20210129","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.forsciint.2005.12.011","article-title":"Stability of Delta(9)-tetrahydrocannabinol (THC) in oral fluid using the Quantisal collection device.","volume":"164","author":"Moore","year":"2006","journal-title":"Forensic Sci Int"},{"key":"R39-10-20210129","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/jat\/30.8.614","article-title":"Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device.","volume":"30","author":"Quintela","year":"2006","journal-title":"J Anal Toxicol"},{"key":"R40-10-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.forsciint.2007.03.038","article-title":"Development and validation of the Cozart DDS oral fluid collection device.","volume":"170","author":"Speedy","year":"2007","journal-title":"Forensic Sci Int"},{"key":"R41-10-20210129","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.forsciint.2004.10.013","article-title":"Validation of the Cozart microplate EIA for analysis of opiates in oral fluid.","volume":"154","author":"Cooper","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R42-10-20210129","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.forsciint.2005.06.011","article-title":"Validation of the Cozart (R) amphetamine microplate EIA for the analysis of amphetamines in oral fluid.","volume":"159","author":"Cooper","year":"2006","journal-title":"Forensic Sci Int"},{"key":"R43-10-20210129","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jchromb.2006.03.020","article-title":"A validated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid.","volume":"835","author":"Scheidweiler","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R44-10-20210129","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jpba.2006.01.041","article-title":"Validation of a gas chromatography-ion trap tandem mass spectrometry for simultaneous analyses of cocaine and its metabolites in saliva.","volume":"41","author":"Cognard","year":"2006","journal-title":"J Pharm Biomed Anal"},{"key":"R45-10-20210129","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.forsciint.2007.03.034","article-title":"Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.","volume":"170","author":"Concheiro","year":"2007","journal-title":"Forensic Sci Int"},{"key":"R46-10-20210129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jchromb.2007.02.016","article-title":"Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid.","volume":"852","author":"Moore","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R47-10-20210129","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jms.846","article-title":"Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography\/electron impact mass spectrometry.","volume":"40","author":"Gunnar","year":"2005","journal-title":"J Mass Spectrom"},{"key":"R48-10-20210129","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.forsciint.2007.03.026","article-title":"Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization.","volume":"170","author":"Teixeira","year":"2007","journal-title":"Forensic Sci Int"},{"key":"R49-10-20210129","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1258\/0004563054255632","article-title":"Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid.","volume":"42","author":"Allen","year":"2005","journal-title":"Ann Clin Biochem"},{"key":"R50-10-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.forsciint.2004.12.040","article-title":"Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS\/MS.","volume":"150","author":"Kintz","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R51-10-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.chroma.2005.03.031","article-title":"Quantitative analysis of Delta(9)-tetrahydrocannabinol in preserved oral fluid by liquid chromatography-tandem mass spectrometry.","volume":"1082","author":"Laloup","year":"2005","journal-title":"J Chromatogr A"},{"key":"R52-10-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.forsciint.2004.11.027","article-title":"Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry.","volume":"150","author":"Wood","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R53-10-20210129","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1373\/clinchem.2006.074237","article-title":"Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry.","volume":"53","author":"Oiestad","year":"2007","journal-title":"Clin Chem"},{"key":"R54-10-20210129","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.forsciint.2004.11.025","article-title":"Proficiency testing (external quality assessment) of drug detection in oral fluid.","volume":"150","author":"Clarke","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R55-10-20210129","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/31.5.276","article-title":"Driving under the influence of drugs-amphetamine concentrations in oral fluid and whole blood samples.","volume":"31","author":"Engblom","year":"2007","journal-title":"J Anal Toxicol"},{"key":"R57-10-20210129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.forsciint.2007.03.028","article-title":"Drugs in oral fluid in randomly selected drivers.","volume":"170","author":"Drummer","year":"2007","journal-title":"Forensic Sci Int"},{"key":"R58-10-20210129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugpo.2005.12.004","article-title":"Driving, drug use behaviour and risk perceptions of nightclub attendees in Victoria, Australia.","volume":"17","author":"Degenhardt","year":"2006","journal-title":"Int J Drug Policy"},{"key":"R59-10-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.forsciint.2004.12.039","article-title":"Drugs in injured drivers in Denmark.","volume":"150","author":"Bernhoft","year":"2005","journal-title":"Forensic Sci Int"},{"key":"R60-10-20210129","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2006.08.020","article-title":"Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients.","volume":"87","author":"Dams","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"R61-10-20210129","first-page":"19673","article-title":"Proposed guidelines for mandatory drug testing.","volume":"69","year":"2004","journal-title":"Fed Regist"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e318167d563","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:40:26Z","timestamp":1786038026000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200804000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e318167d563","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}